ArticlePM & R : the journal of injury, function, and rehabilitation2025
Opioid consumption after lower limb amputation in Medicare beneficiaries.
Article in PM & R : the journal of injury, function, and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Opioid consumption after lower limb amputation in Medicare beneficiaries.PM & R : the journal of injury, function, and rehabilitation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite targeted national quality improvement initiatives, opioid prescription and use patterns after lower limb amputation are not well studied.
objectiveTo determine risk factors associated with extended opioid use and rates of high-risk opioid prescribing after lower limb amputation. DESIGN AND
settingA retrospective population-based study was performed by querying a 20% national sample of Medicare claims of patients undergoing lower limb amputation from 2009 to 2018. Patients were excluded if they did not discharge home or had subsequent surgery 180 days after discharge. Extended opioid use was defined as one opioid prescription filled within 90 days after discharge and another within 90-180 days. Chronic opioid users were defined as having a 180-day supply over the preoperative surgical period and at least one opioid prescription within 60 days of surgery. High-risk opioid prescribing included overlapping opioid prescriptions, overlapping benzodiazepine-opioid prescriptions, high daily doses >100 oral morphine milligram equivalents, multiple prescribers, and new long-acting opioid use within 90 days postoperatively. Multilevel mixed-effects logistic regression and the Cochran-Armitage Trend Test was used. MAIN OUTCOME: New persistent and prolonged opioid use following lower extremity amputation.
resultsThe study included 5191 patients (nonchronic opioid users = 3759, chronic opioid users = 1432). Among the nonchronic opioid users, 873 (23.2%) had new persistent opioid use after surgery. In these patients, age < 55 years (odds ratio [OR], 1.41, p = .04), concurrent gabapentinoid fills (OR, 1.92, p < .001), and sedative/anxiolytic fills (OR, 1.75, p < .001) were associated with new persistent use. Of the chronic opioid users, 1306 (91.2%) had prolonged opioid use after surgery. Rates of high-risk prescribing did not change significantly during the study period, and 82.3% of chronic opioid users were exposed to high-risk prescribing.
conclusionsExtended opioid use is common following lower extremity amputation. Moreover, high-risk prescribing practices remain common and have not changed over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.